Market Research Industry Today

Active Pharmaceutical Ingredients (API) Market to Expand at 6.5% CAGR between 2014 and 2020 - Transparency Market Research

A market report published by Transparency Market Research is Active Pharmaceutical Ingredients (API) Market: (Branded/Generic/Over-the-counter, Chemical/Biological, Captive/Contract Manufactured, by Geography, and by Therapeutic Area) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020
Published 07 September 2015

The global active pharmaceutical ingredients (API) market stood at US$119.7 billion in 2013.The report, titled “Active Pharmaceutical Ingredients (API) Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020”, estimates the global API market to expand at a CAGR 6.5% between 2014 and 2020 and reach a value of US$185.90 billion by the end of the forecast period.The market for captive or in-house API manufacturing is the dominant segment of the global API market, based on the manufacturing type. However, the market is likely to lose ground to the API contract manufacturing market owing to the former’s increased competition, which has decreased its profitability, states the report.  

The generic prescription drugs market leads the global API drug market, whereas the market for oncology drugs is expected to register the fastest growth in the global market for APIs, based on therapeutic areas. The development of the oncology market is expected to boost demand for APIs significantly in the global arena.Synthetic chemical APIs and biological APIs are the two major components of the global API market based on API types. Major pharmaceutical enterprises are focusing extensively on the market for biological APIs, resulting in massive expansion of this market segment. 

North America, Europe, Asia Pacific, and the Rest of the World are the major regional API markets, wherein North America has emerged as the leader owing to the growth of research and development programs in the field of medical sciences, drugs, and therapies. The research report projects this regional market to maintain its leading position during the forecast period.The API market in Asia Pacific is determined to be the most attractive regional market by TMR analysts due to the presence of a large base of generic medicine producers in this region. The market is expected to report the fastest growth over the forecast period.The research report provides a comprehensive analysis of the market structure and value of the global API market, including an evaluation of the forces driving the growth of this industry as well as the limitations and challenges this industry is facing in the global scenario.

Get Sample Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1690

The report also provides market projections for the coming years on the basis of recent technological developments with an in-depth assessment of the company profiles of the major participants operating in the global API industry.Actavis plc, BASF SE, Boehringer Ingelheim, Cambrex Corp., Dr. Reddy’s Laboratories Ltd., Mylan Inc., Lonza Group, Hospira Inc., Novartis International AG, WuXi Apptec, Pfizer Inc., and Teva Pharmaceutical Industries Ltd. are the key players in the global API market. An analysis of the macro and micro economic factors, important for the existing players as well as new market entrants, is also included in this report.

Browse the full Active Pharmaceutical Ingredients (API) Market: (Branded/Generic/Over-the-counter, Chemical/Biological, Captive/Contract Manufactured, by Geography, and by Therapeutic Area) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 – 2020 report at http://www.transparencymarketresearch.com/active-pharmaceutical-ingredients.html

The global active pharmaceutical ingredients market is segmented into:

By Manufacturing Types

  • Captive or In-house API manufacturing
  • API contract manufacturing 

By API Types

  • Synthetic Chemical API
  • Biological API

By Drug Types

  • Branded or Innovative Prescription Drugs
  • Generic Prescription Drugs
  • Over-the-counter Drugs

By Therapeutic Area

  • Non-steroidal Anti-inflammatory Drugs (NSAIDs)
  • Oncology Drugs
  • Anti-diabetic Drugs
  • Cardiovascular Drugs
  • Central Nervous System Drugs
  • Musculoskeletal Drugs
  • Other Drugs (antibacterial, antiviral, antifungal, etc.)

By Regions

  • North America
  • Europe
  • Asia Pacific
  • Rest of the World (RoW)

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. 

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contacts

Mr. Nachiket

90 State Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com/

 

Other Industry News

Ready to start publishing

Sign Up today!